CNBX Pharmaceuticals Inc. Shares Outstanding

Quick Answer

CNBX Pharmaceuticals Inc. reported Shares Outstanding of 553.96 million shares for fiscal year 2025.

CNBX Pharmaceuticals Inc. Shares Outstanding — Annual History

Fiscal Year Shares Outstanding YoY Change
2025 553.96M +1680.6%
2024 31.11M +37.6%
2023 22.61M +1725.5%
2022 1.24M -99.2%
2021 148.66M +10.1%
2020 135.08M +0.4%
2019 134.50M +10.6%
2018 121.58M +1.7%
2017 119.54M +11.5%
2016 107.22M +5.6%
2015 101.50M +1.3%
2014 100.25M +7269.1%
2013 1.36M

Quarterly Shares Outstanding

Quarter Ending Shares Outstanding YoY QoQ
November 30, 2025 753.20M +2321.0% +36.0%
August 31, 2025 553.96M +1680.6% +498.8%
May 31, 2025 92.51M +2873.3% +173.2%
February 28, 2025 33.86M +988.3% +8.8%
November 30, 2024 31.11M +9.9% +0.0%
August 31, 2024 31.11M +37.6% +899.9%
May 31, 2024 3.11M -80.6% +0.0%
February 29, 2024 3.11M +40.8% -89.0%
  • CNBX Pharmaceuticals Inc. showed an increase of +1680.6% in Shares Outstanding compared to the prior fiscal year.
  • Over the 2013–2025 period, CNBX Pharmaceuticals Inc.’s shares outstanding has grown by 40620.4% (from 1.36 million shares to 553.96 million shares).
  • The most recent figure is from CNBX Pharmaceuticals Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on December 1, 2025.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment